tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Yanan Zhu, 44 are a BUY (72.13%), 17 are a HOLD (27.87%).
Analyst Yanan Zhu, currently employed at WELLS FARGO, carries an average stock price target met ratio of 45.21% that have a potential upside of 59.59% achieved within 106 days.
Yanan Zhu’s has documented 120 price targets and ratings displayed on 18 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on NTLA, Intellia Therapeutics at 18-Nov-2024.
Analyst best performing recommendations are on AGLE (AEGLEA BIO THERAPEUTICS).
The best stock recommendation documented was for AGLE (AEGLEA BIO THERAPEUTICS) at 10/28/2022. The price target of $37.5 was fulfilled within 13 days with a profit of $14.5 (63.04%) receiving and performance score of 48.49.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$617
$-2.39 (-0.39%)
$617
12 days ago
(20-Nov-2024)
27/27 (100%)
$42.46 (7.39%)
159
Hold
$715
$95.61 (15.44%)
$408
27 days ago
(05-Nov-2024)
5/7 (71.43%)
$120.26 (20.22%)
85
Buy
$670
$50.61 (8.17%)
$640
28 days ago
(04-Nov-2024)
11/13 (84.62%)
$77.6 (13.10%)
242
Buy
$606
$-13.39 (-2.16%)
$468
1 months 1 days ago
(01-Nov-2024)
14/14 (100%)
$10.42 (1.75%)
174
Buy
$665
$45.61 (7.36%)
$585
1 months 1 days ago
(01-Nov-2024)
11/12 (91.67%)
$69.42 (11.66%)
163
Which stock is Yanan Zhu is most bullish on?
Which stock is Yanan Zhu is most reserved on?
What Year was the first public recommendation made by Yanan Zhu?
